Marshall Jonathan Urist
Head of Research & InvestmentsDr. Marshall Jonathan Urist M.D., PhD is Analyst of Morgan Stanley. Dr. Urist is Head of Research & Investments of Royalty Pharma plc. from 2026 and served as its Executive Vice President of Research & Investments until 2026. Dr. Urist joined the Royalty Pharma plc in 2013. Dr. Urist was Executive VP and Head of Research & Investments of Royalty Pharma plc from 2022. Dr. Urist was Executive Vice President of Research & Investments of Royalty Pharma plc. Dr. Urist was Executive VP and Co-Head of Research & Investments of Royalty Pharma plc from December 2020. Dr. Urist was Executive VP & Head of Research and Investments of RP Management, LLC. Dr. Urist was Senior Vice President of Research & Development of RP Management, LLC from July 19, 2013. Dr. Urist joined the RP Management, LLC on July 19, 2013. Dr. Urist was Vice President of Morgan Stanley, Research Division. Dr. Urist was employed at Morgan Stanley, Research Division until May 09, 2013. Dr. Urist focused on Hospital Supplies and Medical Technology. Dr. Urist has M.D. from Johns Hopkins University, Ph.D. from Columbia University.
Positions
- Company NameRoyalty Pharma plcStock CodeRPRXPositionHead of Research & InvestmentsColleagues
- PLPablo LegorretaFounder, Chairman of the Board & CEO
- TPTerrance P. CoyneExecutive VP & CFO
- CHChristopher HiteChairman of Partnering & Investments
- GBGreg Butz Executive Vice President of Partnering & Investments
- GNGregory NordenIndependent Director
- TWTed W. LoveLead Independent Director
- DCDavid Charles HodgsonIndependent Director
- BLBonnie L. BasslerIndependent Director
